Latest Pharmacy News
One in Five State Medicaid Programs Cover Antiobesity Medications
posted March 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma
posted March 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
COVID-19 Viral Load Rebound Can Occur After VV116, Nirmatrelvir-Ritonavir
posted March 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Second Primary Malignancies Represent Small Proportion of Adverse Events After CAR T-Cell Therapy
posted March 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Study IDs Real-World Reasons for Lemborexant Discontinuation 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia .jpg)
Health Consequences Vary by Chemo Regimen in Testicular Cancer Survivors Related Articles
Nonmedical Expense Reimbursement May Make Cancer Trials More Accessible .jpg)
Rates of Drug Use-Associated Infective Endocarditis Declined From 2020 to 2022 
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain 
Study Looks at Approaches to Prescribing Obesity Medications for Older Adults Pharmacy Conference Highlights
Pharmacy Monthly Briefings
Pharmacy Conference News
Stay Connected
